athira pharma stock symbol
102 rows Discover historical prices for ATHA stock on Yahoo Finance. View the latest ATHA stock quote and chart on MSN Money.
Why Athira Pharma Stock Dropped Today The Motley Fool
02102022 174628 1-888-992-3836 Free.
. A high-level overview of Athira Pharma Inc. Volume 225454 Market Cap 12140 M Dividend 000 000 Beta. Common Stock ATHA Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.
The Company is focused on developing small molecules to restore neuronal health and stop. Dive deeper with interactive charts and top stories of Athira Pharma Inc. ATHA a late clinical-stage biopharmaceutical company focused on developing small molecules to.
Athira Pharma Inc 350 029 903 3rd Party Ad. Free forex prices toplists indices and lots more. Get Athira Pharma Inc ATHANASDAQ real-time stock quotes news price and financial information from CNBC.
13894 BNTX245 Ionis Pharmaceuticals Inc 4652 IONS035 In the news MarketScreener 14 hours ago ATHIRA PHARMA INC. Stock Quote Chart. Athira Pharma Inc.
Athira Pharma - ATHA Stock Forecast Price News 351 001 029 As of 10182022 1213 PM ET Todays Range 347 361 50-Day Range 293 396 52-Week. Is a clinical-stage biopharmaceutical company. Athira Pharma ATHA stock price charts trades the USs most popular discussion forums.
Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. View daily weekly or monthly format back to when Athira Pharma Inc. Enter Symbol Stock Activity Open 333 Day Low 320 Day High 338 52 Wk Low 253 52 Wk High 1665 Avg.
ATHA Athira Pharma Inc Stock Price and Discussion Stocktwits. Todays HighTodays Low52 Week High52 Week Low. BOTHELL Wash July 25 2022 GLOBE NEWSWIRE -- Athira Pharma Inc.
Athira Pharma Provides Update on Plans for Ongoing LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimers Patients. Find real-time ATHA - Athira Pharma Inc stock quotes company profile news and forecasts from CNN Business. Athira Pharma Inc a late clinical-stage biopharmaceutical company focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Athira Pharma Inc headquartered in the Seattle Washington area is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore. Not an offer or recommendation by Stocktwits. Other Events Regulation FD Disclosure Financial.
Stock analysis for Athira Pharma Inc ATHANASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. Data Provided by Refinitiv. Minimum 15 minutes delayed.
Why Athira Pharma Stock Dropped Today Prosper Junior Bakiny Jan 21 2021 The clinical-stage biopharma company announced the pricing of a public stock offering.
Atha Investor Alert Bronstein Gewirtz Grossman Llc Notifies Athira Pharma Inc Investors Of Class Action And Encourages Shareholders To Contact The Firm Oneida Dispatch
Gdzdlqpmw40cwm
Athira Pharma Inc Proxy Soliciting Materials Dfan14a
Sec Filing Athira Pharma
Athira Pharma Inc Form Dfan14a Filed 2022 04 25
Atha Athira Pharma Inc Stock Overview U S Nasdaq Barron S
Bothell Biotech Firm And Activist Investor Feud Over Control Of Alzheimer S Research The Seattle Times
Athira Pharma Inc Atha Stock Price Quote News Stock Analysis
Athira Pharma Inc Form Dfan14a Filed 2022 04 25
Gdzdlqpmw40cwm
Atha 424b4 Htm
Atha Alert Nationally Ranked Shareholder Rights Firm Labaton Sucharow Is Investigating Athira Pharma Inc Nasdaq Atha For Potential Securities Violations And Breach Of Fiduciary Duty
Seattle Biotech Athira Pharma Sets Terms For Ipo Aims To Raise Up To 170m Geekwire
Athira Chief Executive Resigns As Company Confirms She Altered Research
Atha Stock Price And Chart Nasdaq Atha Tradingview
Bpc Academy Intro To Biotech Trading Biopharmcatalyst
Athira Pharma Inc Proxy Soliciting Materials Dfan14a
Athira Pharma Inc Formcorresp 0001564590 20 042400 Athira Pharma Nasdaq Atha Benzinga
Athira Pharma 96 Hour Deadline Alert Former Louisiana Attorney General And Kahn Swick Foti Llc Remind Investors With Losses In Excess Of 100 000 Of Deadline In Class Action Lawsuits Against Athira